Searched for
RLL
Raymond shares surge 8% in 2 days ahead of lifestyle business’ listing tomorrowRaymond Share Price: Raymond's shares rose by 8% over two days, reaching Rs 2,179 on the BSE. This surge comes ahead of the listing of its ...04 Sep, 2024, 12.05 PM IST- Raymond shares jump 9% ahead of listing of lifestyle business. Here's whyRaymond Share Price: Raymond shares jumped 9% to Rs 2,182 ahead of its lifestyle business listing this week. Brokerages, including Motilal ...03 Sep, 2024, 04.54 PM IST
- Raymond shares trade ex-lifestyle business, stock jumps over 4%Raymond's lifestyle business demerger process begins with shareholders receiving new equity shares. The company's stock price rises by near...11 Jul, 2024, 12.06 PM IST
- India-Russia trade body endorses new framework to 15 projectsThe projects include setting-up of JV with HAL as joint centre for development of helicopters, joint project of RLL and government of Yaros...22 Sep, 2013, 02.59 PM IST
- Ranbaxy launches anti-acne drug in the US marketAccording to an analyst, the launch of Absorica would greatly benefit Ranbaxy as there are only 2-3 players currently selling the product i...26 Nov, 2012, 02.26 PM IST
- Ranbaxy labs gets Health Canada nod for cholesterol lowering drugRanbaxy Labs said it has received approval from the Health Canada to manufacture & mkt its generic RAN-Rosuvastatin tablets used for loweri...31 Mar, 2012, 03.03 PM IST
- HDFC recommends 'sell' on Ranbaxy for target of Rs 230HDFC Securities has downgraded Ranbaxy Laboratories (RLL) from Hold to “Sell” with a price target of Rs 230 per share in its post-result up...03 Mar, 2010, 11.09 AM IST
- Lupin buys Baroda co RubaminRLL, a subsidiary of the Rubamin group, manufactures advanced intermediates and Active Pharmaceutical Ingredients (APIs) and provides resea...28 Sep, 2007, 12.33 AM IST
- Lupin acquires pharma business of RubaminDrug maker Lupin Ltd on Thursday said it has acquired the pharmaceutical business of Rubamin group, for an undisclosed amount.27 Sep, 2007, 12.15 PM IST
- Ranbaxy receives USFDA's nod for pain reliefRanbaxy Laboratories to manufacture and market Hydrocodone Bitartrate and Acetaminophen tablets in the US.20 Aug, 2007, 03.37 PM IST
- Gets Norway nod to market Atorvastatin eRanbaxy Laboratories (RLL) announced that the Norwegian Appeals Court has given a favourable decision for Ranbaxy in its case against Pfize...30 May, 2007, 03.02 AM IST
- Ranbaxy wins on all 4 Atorvastatin Patents in NorwayRanbaxy Laboratories Limited (RLL) announced that the Norwegian Appeals Court today handed down a favorable decision for Ranbaxy in its cas...29 May, 2007, 08.30 PM IST
- Ranbaxy gets US nod to mkt its drugGurgaon-based pharmaceutical major Ranbaxy Labs today announced that RLL has received approval from the US Food and Drug Administration to ...31 Jan, 2007, 10.40 PM IST
- Ranbaxy to mkt hypertension drug in USThe company has got FDA approval to market atenolol tablets of strengths 25 mg, 50 mg, and 100 mg.02 Jan, 2007, 03.15 PM IST
- Ranbaxy wins on two additional patents in NorwayIn yet another boost to India's biggest drug maker Ranbaxy Laboratories, a Norwegian court has ruled in its favour in the patent litigation...30 Aug, 2006, 12.20 PM IST
- Ranbaxy gets approval to produce, sell anti-AIDS drugCountry's largest drug maker, Ranbaxy Laboratories Limited (RLL) on Monday said it had received approval to manufacture and market anti-AID...14 Aug, 2006, 07.49 PM IST
- Ranbaxy gets USFDA nod for antibioticRanbaxy Laboratories Limited (RLL) on Friday said it had received approval from the US Food and Drug Administration to manufacture and mark...30 Jun, 2006, 10.00 PM IST
Load More
